Science Daily·4 min read·medium
A hidden weakness in deadly cancers could lead to powerful new treatments
✦AI Summary
UCLA researchers have discovered that certain aggressive cancers lacking the RB gene are highly dependent on the E2F3 protein for survival. This 'synthetic lethality' provides a potential new target for developing therapies for previously untreatable tumors.
Researchers at UCLA have identified a hidden weakness in some of the most aggressive and difficult-to-treat cancers, raising hopes for a new way to attack tumors that have resisted treatment for decades.
healthscience
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in